Finally, very recent research showed that tumor-targeting therapy of osteosarcoma (OS) can be performed by a highly effective engineered and MEG3-loaded exosome, as a combination of MEG3 and exosome significantly increased MEG3 therapeutic effect [142]. This evidence concerns the gene MEG3 and neoplasm.